Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for Noise-Induced Hearing Loss in Skull-Based Surgery
NCT04768569Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zonisamide in noise-induced hearing loss (NIHL), sponsored by Washington University School of Medicine. Started Oct 2021; status: terminated.
02
Drugs
zonisamide
03
Conditions
noise-induced hearing loss (NIHL)
Beyond the preview
Go deeper on NCT04768569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04768569.